Terry B. Ernest

1.5k total citations
25 papers, 1.1k citations indexed

About

Terry B. Ernest is a scholar working on Pediatrics, Perinatology and Child Health, Economics and Econometrics and Pharmaceutical Science. According to data from OpenAlex, Terry B. Ernest has authored 25 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pediatrics, Perinatology and Child Health, 6 papers in Economics and Econometrics and 5 papers in Pharmaceutical Science. Recurrent topics in Terry B. Ernest's work include Pharmaceutical studies and practices (17 papers), Pharmaceutical Economics and Policy (5 papers) and Child Nutrition and Feeding Issues (3 papers). Terry B. Ernest is often cited by papers focused on Pharmaceutical studies and practices (17 papers), Pharmaceutical Economics and Policy (5 papers) and Child Nutrition and Feeding Issues (3 papers). Terry B. Ernest collaborates with scholars based in United Kingdom, Switzerland and United States. Terry B. Ernest's co-authors include Catherine Tuleu, Felipe L. Lopez, Mine Orlu Gul, Fang Liu, Sejal R. Ranmal, Hannah Batchelor, Jennifer Walsh, Talia Flanagan, Mine Orlu-Gul and David Clapham and has published in prestigious journals such as Scientific Reports, International Journal of Pharmaceutics and Drugs.

In The Last Decade

Terry B. Ernest

24 papers receiving 1.1k citations

Peers

Countries citing papers authored by Terry B. Ernest

Since Specialization

Citations

This map shows the geographic impact of Terry B. Ernest's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Terry B. Ernest with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Terry B. Ernest more than expected).

Fields of papers citing papers by Terry B. Ernest

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Terry B. Ernest. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Terry B. Ernest. The network helps show where Terry B. Ernest may publish in the future.

Co-authorship network of co-authors of Terry B. Ernest

This figure shows the co-authorship network connecting the top 25 collaborators of Terry B. Ernest. A scholar is included among the top collaborators of Terry B. Ernest based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Terry B. Ernest. Terry B. Ernest is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Advancing research and development of anti-infectives for children with a focus on antiretroviral therapy: A clinical development perspective	International Journal of Antimicrobial Agents	Ann M. Buchanan, Adrie Bekker et al.	1
2	Opportunities for enteral drug delivery for neonates, infants, and toddlers: a critical exploration	Expert Opinion on Drug Delivery	Catherine Tuleu, Terry B. Ernest et al.	8
3	Tafenoquine exposure assessment, safety, and relapse prevention efficacy in children with Plasmodium vivax malaria: open-label, single-arm, non-comparative, multicentre, pharmacokinetic bridging, phase 2 trial	The Lancet Child & Adolescent Health	Iván Darío Vélez, Tran Tinh Hien et al.	7
4	‘Big Data’ informed drug development: a case for acceptability	Drug Discovery Today	Andrew J. Edwards, Terry B. Ernest et al.	2
5	Application of the Stable Isotope Label Approach in Clinical Development—Supporting Dissolution Specifications for a Commercial Tablet Product with Tafenoquine, a Long Half-life Compound	The AAPS Journal	Navin Goyal, Khadeeja Mohamed et al.	12
6	Acceptability of placebo multiparticulate formulations in children and adults	Scientific Reports	Felipe L. Lopez, Punam Mistry et al.	29
7	Co-Processed Excipients for Dispersible Tablets—Part 2: Patient Acceptability	AAPS PharmSciTech	Karolina Dziemidowicz, Felipe L. Lopez et al.	27
8	Co-Processed Excipients for Dispersible Tablets–Part 1: Manufacturability	AAPS PharmSciTech	Karolina Dziemidowicz, Felipe L. Lopez et al.	48
9	Patient acceptability, safety and access: A balancing act for selecting age-appropriate oral dosage forms for paediatric and geriatric populations	International Journal of Pharmaceutics	Jennifer Walsh, Sejal R. Ranmal et al.	73
10	Non-human tools for the evaluation of bitter taste in the design and development of medicines: a systematic review	Drug Discovery Today	Terry B. Ernest, Catherine Tuleu et al.	44
11	Patient centric formulations for paediatrics and geriatrics: Similarities and differences	International Journal of Pharmaceutics	Sara M. Hanning, Felipe L. Lopez et al.	44
12	Towards the development of a paediatric biopharmaceutics classification system: Results of a survey of experts	International Journal of Pharmaceutics	Hannah Batchelor, Terry B. Ernest et al.	16
13	Effect of formulation variables on oral grittiness and preferences of multiparticulate formulations in adult volunteers	European Journal of Pharmaceutical Sciences	Felipe L. Lopez, Mine Orlu Gul et al.	58
14	Formulation approaches to pediatric oral drug delivery: benefits and limitations of current platforms	Expert Opinion on Drug Delivery	Felipe L. Lopez, Terry B. Ernest et al.	191
15	Formulation factors affecting acceptability of oral medicines in children	International Journal of Pharmaceutics	Fang Liu, Sejal R. Ranmal et al.	37
16	Patient-Centered Pharmaceutical Design to Improve Acceptability of Medicines: Similarities and Differences in Paediatric and Geriatric Populations	Drugs	Fang Liu, Sejal R. Ranmal et al.	173
17	Application of in vitro biopharmaceutical methods in development of immediate release oral dosage forms intended for paediatric patients	European Journal of Pharmaceutics and Biopharmaceutics	Hannah Batchelor, Rainer Alex et al.	38
18	A benefit/risk approach towards selecting appropriate pharmaceutical dosage forms – An application for paediatric dosage form selection	International Journal of Pharmaceutics	Terry B. Ernest, Jennifer Walsh et al.	50
19	Preparation of medicines for children – A hierarchy of classification	International Journal of Pharmaceutics	Terry B. Ernest, Anthony J Nunn et al.	43
20	Specific aspects of gastro-intestinal transit in children for drug delivery design	International Journal of Pharmaceutics	Terry B. Ernest, David Clapham et al.	66

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact